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Abstract  
The regulated expression of ADAMTS2 (a disintegrin and metalloproteinase with thrombospondin motifs), a 
secreted metalloproteinase involved in the processing of procollagen to collagen, was studied in peripheral blood 
mononuclear cells (PBMC). Stimulation with glucocorticoids (GC) resulted in a pronounced dose-and time-
dependent increase of ADAMTS2 mRNA levels in PBMC. The increase of ADAMTS2 expression was specific 
for CD14++ monocytes (440-fold) and alveolar macrophages (200-fold), whereas CD3+ (T lymphocytes), 
phytohemagglutinin-activated CD3+ (T lymphocytes), and CD19+ (B lymphocytes) showed no significant 
changes in ADAMTS2 mRNA after GC treatment. Treatment of monocyte-derived macrophages (MDM) with 
GC also resulted in an increase of ADAMTS2 protein in the culture tissue media. Using the GC analog RU486, 
GC-mediated induction of ADAMTS2 mRNA was blocked, implicating that GC acts specifically via the GC-
receptor. In agreement with findings in blood monocytes, cell lines of the monocytic lineage (MM6, THP-1) 
showed significant GC-induced significant increases in ADAMTS2 mRNA, while in epithelial cells (A549, Calu-
3, Colo320, BT-20) and fibroblast (MRC-5, WI-38, and two NHDF-c cell types from adult cheek and upper 
arm), they showed no or little responsiveness to GC. As macrophages have important functions in immune 
defense and tissue homeostasis, these findings suggest that GC-mediated specific induction of ADAMTS2 in 
these cells may play a crucial role in the resolution of inflammation and wound repair. 
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Introduction 
The major functions of monocytic cells within the immune system are to regulate local inflammatory reactions 
by releasing pro- and anti-inflammatory molecules, to support a primary defense mechanism via phagocytosis 
and respiratory burst, and to mediate immune responses by antigen-processing, antigen-presentation, and 
cytokine production [1]. Based on these properties, macrophages play a key role in inflammation and immune 
activation. In addition, macrophages are central to tissue homeostasis in that they are involved in wound repair 
and tissue remodeling, secreting critical mediators like TGFβ and metalloproteinases [2, 3], The properties of the 
macrophages are strongly influenced by GC. The effects of GC on immunological functions involves potent anti-
inflammatory and immunosuppressive properties [4]. The anti-inflammatory effect of GC is mediated through an 
inhibitory effect on proinflammatory transcription factors such as NF-KB [5], which results in reduced cytokine 
expression. In cell mediated immunity, reduced IL-2 levels lead to decreased T cell proliferation and activation. 
Humoral immunity is suppressed by inhibiting IL-2 and IL-2 receptor expression which, in turn, reduces B cell 
expansion and subsequent antibody production [6]. In macrophages, GC upregulate annexin-1 expression which 
suppresses phospholipase A2 activity and, thereby, limits the availability of arachidonic acid for the synthesis of 
eicosanoids like prostaglandin and leukotriene, which are crucial for acute inflammatory responses[7]. 
Besides these well-known mechanisms, monocytes/macrophages also play a major role in modifying the 
structure of the surrounding tissue. Recent findings indicate that the action of GC is also mediated by 
suppression of another pro-inflammatory transcription factor, activator protein-1 (AP-1). Activation of AP-1 
induces the transcription of several pro-inflammatory genes, including that of the metalloproteinases MMP-2 and 
MMP-9. These MMPs hydrolyze extracellular matrix proteins such as collagen, which normally function to 
localize inflammatory reactions within tissues [8, 9, 10]. Suppression of AP-1 activity by GC reduces expression 
of MMP-2 and MMP-9 and, thus, may limit the extent of inflammation. 
Another important family of enzymes that modify extracellular matrix proteins is the ADAMTS (a disintegrin 
and metalloproteinase with thrombospondin motifs) protease family. In humans, this enzyme family is 
comprised of 19 members, the domain structure of these enzymes is complex and consists of an N-terminal 
reprolysin-type pro-metalloproteinase domain attached to a C-terminal ancillary domain, which contains at least 
one thrombospondin type 1 repeat [11]. After secretion, ADAMTS enzymes undergo processing, including 
cleavage of the N-terminal signal peptide and pro-domain and of the C-terminal region, which affects substrate 
specificity and localization of the enzymes [12]. Their known functions include collagen processing 
(ADAMTS2, 3, 14), cleavage of matrix proteoglycans (ADAMTS4, 5), inhibition of angiogenesis (ADAMTS1, 
8), and blood coagulation homoeostasis (ADAMTS13) [11]. 
ADAMTS2 is a procollagen N-proteinase that cleaves procollagen I, II, and III to the corresponding collagens 
and is required to generate collagen monomers that are able to assemble into elongated and cylindrical collagen 
fibrils [13]. Collagen is a major constituent of the extracellular matrix. In humans, mutation in the ADAMTS2 
gene causes the dermatosparactic type of Ehlers-Danlos syndrome (previously known as Ehlers-Danlos 
syndrome type VIIC), a disease mainly characterized by an extreme skin fragility. Besides this, a properly 
processed collagen is crucial for a functional assembly of the extracellular matrix (ECM), which is, in turn, 
responsible for ECM-cell interactions necessary not only for providing cells with mechanical stability, but also 
for physiological events like lineage decisions during embryogenesis, differentiation, cell migration, and wound 
repair [14]. 
We show herein that the expression of ADAMTS2, a protease involved in collagen synthesis, is strongly induced 
by GC in a tissue-specific fashion only for cells of the monocyte/macrophage lineage but marginal in many other 
cell types including fibroblasts and epithelial cells. 
Materials and methods 
Donors, isolation of peripheral blood mononuclear cells, and alveolar macrophages 
Human PBMC were isolated from heparinized (10 U/ml) blood from healthy human volunteers by density 
gradient centrifugation (Lymphoprep, 1.077 g/ml, no. 1053980, Axis-Shield PoC AD, Oslo, Norway). Cells were 
directly used for subsequent isolation of monocytes or cultured under LPS-free conditions. Written informed 
consent was obtained from each individual. The protocol was approved by the Ethics Committee of the Medical 
School of the Ludwig-Maximilians-University (Munich, Germany). 
Human alveolar macrophages were obtained from bronchoalveolar lavage (BAL) that was performed on patients 
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with sarcoidosis or fibrosis. After informed consent, lavage was performed during fiberoptic bronchoscopy by 
instilling 160 ml of 0.9% saline solution in 20 ml aliquots into the lingula or middle lobe and withdrawing the 
fluid immediately. All patients underwent the lavage procedure for routine diagnostic purpose and leftover 
material used herein. 
Bovine heparinized (10 U/ml) blood from apparently healthy cows was obtained from the animal clinic, 
department "Innere Medizin und Chirurgie der Wiederkäuer" of the Ludwig-Maximilians-University (Munich-
Oberschleissheim, Germany) and PBMC were isolated as mentioned above. 
Cells and culture medium 
Primary human and bovine cells, the monocytic cell lines Mono Mac 6 [15], THP-1 [16], BT-20 [17], Colo320 
[18], and NHDF-c adult from cheek and upper arm (PromoCell, Heidelberg, Germany) were cultured in RPMI 
1640 medium (no. F1415, Biochrom, Berlin, Germany), containing OPI (oxaloacetate, pyruvate, insulin; no. O-
5003, Sigma, Taufkirchen, Germany), L-glutamine 2 mM (no. 15140-114, Invitrogen, Karlsruhe, Germany), 
penicillin 200 U/ml/streptomycin 200 µg/ml (no. 15140-114, Invitrogen, Karlsruhe, Germany), and 1× 
nonessential amino acids (no. 11140-35, Invitrogen, Karlsruhe, Germany). After the addition of supplements, the 
medium was ultra-filtered through a Gambro 2000 column (Gambro, Hechingen, Germany) to remove any 
inadvertent LPS contamination, followed by the addition of 10% FCS (no. S0115, Biochrom, Berlin, Germany). 
The cell lines MRC-5 [19], WI-38 [20], A549 [21], and Calu-3 [22] were cultured in Dulbecco's minimal 
essential medium NUT mix F12 (no. 21331-020, Invitrogen, Karlsruhe, Germany), containing 10% FCS (no. 
S0115, Biochrom, Berlin, Germany), L-glutamine 2 mM (no. 15140-114, Invitrogen, Karlsruhe, Germany), and 
penicillin 200 U/ml/streptomycin 200 µg/ml (no. 15140-114, Invitrogen, Karlsruhe, Germany). 
Enrichment of CD14++ monocytes and generation of monocyte-derived macrophages 
For cell enrichment, the MACS magnetic separation technique was used (all columns and reagents from Miltenyi 
Biotec, Bergisch-Gladbach, Germany). For isolation of CD14++ monocytes, PBMC were in a first step depleted 
of CD16-positive cells. For this, a total of 20 × 10 cells were resuspended in 80 µl of phosphate-buffered saline 
(PBS) containing 25 µl of Anti-CD 16 microbeads (no. 130-045-701). After incubation for 30 min at 4°C, cells 
were washed and resuspended in 1.5 ml PBS, and this was loaded onto a LD column (no. 120-000-497) that was 
positioned in a MidiMACS magnet (no. 130-042-302). Nonadherent cells were recovered and used for 
enrichment of CD14++ cells. For this, anti-CD14 microbeads (no. 130-050-201) was diluted 1:5 in PBS and 
added to the cells to a final volume of 100 µl. After incubation for 30 min at 4°C, cells were washed and 
resuspended in 1.5 ml PBS, and this was loaded onto a LS column (no. 120-000-475). The column was washed 
five times with 2 ml PBS each. Cells were recovered from the column by pressing 2 ml PBS through the column 
for five times. CD14++ cells were washed and resuspended in supplemented RPMI 1640 medium (mentioned 
above). 
To determine purity of the CD14++ monocytes, a sample was stained with FITC-labeled anti-CD14 antibody 
(My4-FITC, no. 6603511, Coulter, Krefeld, Germany) and PE-labeled anti-CD16 antibody (Leu11c-PE no. 
332779, Becton-Dickinson, Heidelberg, Germany) and measured by FACS. CD14++ monocytes with a purity of 
96% or higher were used. 
Enrichment of CD3+ T lymphocytes and CD19+ B lymphocytes 
PBMC were used for enrichment of CD3+ T lymphocytes and CD19+ B lymphocytes. For this, either anti-CD3 
microbeads (no. 130-050-101) or anti-CD19 microbeads (no. 130-050-301) were diluted 1:5 in PBS and added to 
10 × 106 freshly isolated PBMC to a final volume of 100 µl. After incubation for 30 min at 4°C, cells were 
washed and resuspended in 1.5 ml PBS and this was loaded onto a LS column (no. 120-000-475). The column 
was washed five times with 2 ml PBS each. Cells were recovered from the column by pressing 2 ml PBS through 
the column for five times. CD3+ and CD 19+ cells were washed and resuspended in supplemented RPMI 1640 
medium (mentioned above). 
To determine purity of the CD3+ and CD19+ lymphocytes, a sample of each was stained with FITC-labeled anti-
CD3 antibody (no. 1281, Coulter, Krefeld, Germany), or FITC-labeled anti-CD19 antibody (no. F0768, Dako, 
Hamburg, Germany), respectively, and measured by FACS. CD3+ and CD19+ lymphocytes with a purity of 
96% or higher were used. 
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Experimental setup 
For gene expression analysis, cells were cultured in a final concentration of 2 × 106 in 2 ml culture medium per 
well in ultralow attachment tissue plates (no. 3473, Corning Costar, Wiesbaden, Germany) at 37°C and 5% CO2. 
For stimulation with methylprednisolone (MP; no. M-0639, Sigma, Taufkirchen, Germany), cells were incubated 
for 5 days with 1 µM MP or remained untreated as control. For activation of CD3+, T lymphocytes were 
additionally incubated with phytohemagglutinin (PHA; no. 0528-56, Difco Laboratories, Heidelberg, Germany) 
with a final concentration of 5 µg/ml for 5 days. 
For blocking studies of MP action, the glucocorticoid analog RU-486 was used (no. M-8046, Sigma, 
Taufkirchen, Germany) in a final concentration of 2 µM and added to cell culture medium 15 min before MP. 
For Western blot analysis, bovine PBMC were cultured in a final concentration of 1.7 × 107 in 4 ml RPMI 1640 
medium (as detailed above) per well in tissue culture plates (no. 3506, Corning Costar, Wiesbaden, Germany) at 
37°C and 5% CO2 for 3 days, supplemented with 100 ng/ml M-CSF (rh M-CSF, lot no. Ex3-001, kindly 
provided by Genetics Institute, Cambridge Massachusetts, USA) and in the absence or presence of MP (1 (µM). 
On day 3, the medium was changed and replaced with serum-free medium, supplemented with 100 ng/ml M-
CSF and in the absence or presence of MP (1 µM) and cultured for additional 2 days. On day 5, conditioned 
medium and cells were collected separately. 
Total RNA isolation and RT-PCR 
Polymerase chain reaction (PCR) was performed according to the method of Wang and colleagues [23]. Total 
RNA was extracted from MM6 by using TRI Reagent (no. T-9424, Sigma, Taufkrichen, Germany) according to 
the manufacturer's instruction. In brief, cells were lysed in 200 µl TRI Reagent, and 15 µg tRNA as carrier were 
added per sample. After isolation, the RNA was reverse transcribed with oligo(dT) as primer. 
Using the LightCycler system (Roche Diagnostics, Mannheim, Germany)  according to  the  manufacturer's 
instruction, quantitative PCR were performed using the following primers: 
ADATMTS1 [24] 5' primer: 5'-CAG CCC AAG GTT GTA GAT GGT A-3' 
3' primer: 5'-TTC ACT TCG ATG TTG GTG GCT C-3'  
ADATMTS2 [25] 5' primer: 5'-CTG GCA AGC ATT GTT TTA AAG GA-3' 
3' primer: 5'-GGA GCC AAA CGG ACT CCA AG-3'  
ADATMTS3 [26] 5' primer: 5'-TCA GTG GGA GGT CCA AAT GCA-3' 
3' primer: 5'-GCA AAG AAG GAA GCA GCA GCC-3'  
ADATMTS9 [27] 5' primer: 5'-GGA CAA GCG AAG GAC ATC C-3' 
3' primer: 5'-ATC CAT CCA TAA TGG CTT CC-3'  
ADATMTS14 [28] 5' primer: 5'-ACA CCT GTG TGA CCA CAA GAA GAG-3' 
3' primer: 5'-GCA TGA CCT TGT GGG TTC CAT TGG-3' 
ADATMTS20 [27] 5' primer: 5'-GGT GGC ATG TTA TTG GCA AAA-3' 
3' primer:  5'-CAC AGT TAC CAT GGC ATA GTT CTT-3' 
α-enolase 5' primer: 5'-GTT AGC AAG AAA CTG AAC GTC ACA-3' 
3' primer: 5'-TGA AGG ACT TGT ACA GGT CAG-3'  
Of cDNA, 3 µl was used for amplification in the SYBR Green format using the LightCycler-FastStart DNA 
Master SYBR Green I kit from Roche (no. 2239264, Mannheim, Germany). For quantitative PCR, the 
LightCycler system offers the advantage of fast and real-time measurement of fluorescent signals during 
amplification. The SYBR Green dye binds specifically to the minor groove of double stranded DNA. 
Fluorescence intensity is measured after each amplification cycle. During PCR, a doubling of template molecules 
occurs in each cycle only during the log-linear phase. Melting curves have been performed after each 
amplification to ensure that primer dimers did not contribute to the fluorescence intensity of the specific PCR 
product. Amplificates were run out on a gel, and bands were observed on the expected molecular weight. As an 
internal control, the housekeeping gene α -enolase was amplified. 
Western blot 
Conditioned medium (20 ml) was extensively dialyzed in 0.3 M ammonium acetate, lyophilized, and recovered 
in 0.3 ml H2O. Samples (60 µl ) were denatured in Laemmli denaturation buffer containing 0.1 M DTT, 
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submitted to electrophoresis (7.5% SDS-PAGE) and analyzed by Western blotting using a monoclonal antibody 
specific for the fourth TSPI repeat of ADAMTS2 as described before [13], 
Four different products were detected, two of them (150 and 104 kDa) displaying aminoprocollagen peptidase 
activity. 
Oligonucleotide array 
RNA was isolated with TRIzol RNA isolation reagent (Invitrogen, Karlsruhe, Germany), labeled, and hybridized 
to Affymetrx HG U133plus2 arrays (Affymetrix, High Wycombe, UK) according to the manufacturer's 
recommendations. Data were normalized, and transcript-specific gene expression levels were calculated, using 
rma [29], [30] as implemented in R [31] and Bioconductor [32]. Differentially expressed genes were identified 
using the permutation-based method of Tusher et al. [33] (sam) as implemented in the "samr" R package, using 
the median false discovery rate over 100 data permutations as a measure for statistical significance. Genes were 
considered to be differentially expressed when their fluorescence readings were greater than 100 arbitrary units 
and genes showing differences greater than twofold or more. The array data can be accessed at 
http://www.ncbi.nlm. nih.gov/geo/ with the accession number GSE8608. 
Statistics 
For statistical analysis of the data, we used the Student's t test. Results were considered significant if  p<0.05. 
Oligonucleotide array data were statistically analyzed as mentioned above. 
Results 
Effect of MP exposure on ADAMTS2 mRNA expression 
In initial studies, we analyzed the effect of glucocorticoids (GC) on PBMC by incubating these cells in the 
presence or absence of 1 µM methylprednisolone (MP) continuously for 5 days. To quantitate ADAMTS2 mRNA 
levels, we used LightCycler analysis allowing real-time monitoring of cDNA amplification. As shown in Fig. la, 
expression of ADAMTS2 mRNA was induced 165-fold in PBMC treated with MP relative to controls. 
We next examined the dose- and time-dependence of ADAMTS2 expression in MP-stimulated PBMC. MP-con-
centrations of 1 nM and 0.01 µM do not have any effect on ADAMTS2 mRNA expression (Fig. 1b). In contrast, 
MP concentrations of 0.1 µM (71.6-fold ± 36.5) and 1 µM (220-fold ± 90) MP induced a marked increase in 
ADAMTS2 mRNA levels in PBMC. A higher concentration (10 µM) did not induce further increases in 
ADAMTS2 transcriptional expression. 
Time course experiment showed that moderate increases (3.45-fold ± 1) in ADAMTS2 transcript levels can be 
detected as early as 4 h after treatment with MP (Fig. 1c). The increase is more pronounced after 24 and 48 h 
(27-fold ± 9, and 49-fold ± 28, respectively). After 120 h incubation with MP, ADAMTS2 was still highly 
expressed (47.5-fold ± 1). Hence, maximun induction of ADAMTS2 mRNA by GC requires 2 days of culture 
with the hormone. 
MP-induced expression of ADAMTS2 is restricted to blood monocytes 
To determine which of the various leukocytes in PBMC expresses ADAMTS2 upon MP treatment, CD 14++ 
monocytes, CD3+ T lymphocytes, PHA-activated CD3+ lymphocytes, and CD 19+ B lymphocytes were first 
isolated from PBMC using MACS magnetic bead separation. Cells were then stimulated for 5 days with 1 µM 
MP and PHA at 5 mg/ml, respectively, and ADAMTS2 mRNA expression levels  were  analyzed.  During  such  
culture,  monocytes mature and develop into macrophages as evidenced by increases in size, granularity, and 
upregulation of the CD68 marker (data not shown). 
ADAMTS2 expression in T lymphocytes (1.6-fold ± 0.95) and in B lymphocytes (0.52 ± 0.36) showed no effect 
after MP treatment, in PHA-activated T lymphocytes (32.5 ± 49.6), a moderate but also not significant effect 
after MP treatment was seen (Fig. 2). In contrast, MP induced a marked increase in ADAMTS2 levels in 
macrophages derived from CD14++ monocytes (440-fold ± 180). These data show that among PBMC, it is the 
monocytes which respond to MP with a pronounced upregulation of ADAMTS2 mRNA. Monocytes go from 
blood into tissue and develop into macrophages. We therefore have asked whether GC treatment will also induce 
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ADAMTS2 mRNA in macrophages taken from the lung. As shown in Fig. 2, MP led to a substantial 200-fold 
induction of ADAMTS2 gene expression in alveolar macrophages. 
 
Fig. 1 Effect of methylprednisolone (MP) on ADAMTS2 mRNA levels in blood mononuclear cells (PBMC). 
PBMC were isolated from blood of healthy donors by density gradient separation, a Cells were incubated for 5 
days with 1 µM MP or remained untreated. Baseline is untreated cells and was set as 1; n = 5; mean±SD; * p < 
0.05. b For dose-response  effect of methylprednisolone  (MP)  on ADAMTS2.mRNA levels, PBMC was 
incubated for 5 days with different concentrations of MP. Baseline is untreated cells and was set as 1; n = 3; 
mean±SD; *p < 0.05. c For time-dependence effect of methylprednisolone (MP) on ADAMTS2 mRNA levels, 
PBMC was incubated with or without 1 µM MP for different periods of time. Baseline is untreated cells and was 
set as 1; n = 4; mean±SD; *p < 0.05 
 
 
Fig. 2 Effect of methylprednisolone (MP) on ADAMTS2 mRNA levels in CD14++ monocytes (n = 4), CD3+ T 
lymphocytes (n = 3), PHA-activated CD3+ T lymphocytes (n = 6) and CD19+ B lymphocytes (n = 3), 
respectively. Cells were isolated from blood of healthy donors by density gradient separation and subsequent 
enrichment via MACS separation. Cells were incubated for 5 days with 1 µM MP, or 5 µg/ml PHA plus 1µM 
MP, respectively, or remained untreated. Baseline is untreated cells and was set as 1; mean±SD; *p < 0.05 
 
 
Glucocorticoid-receptor mediated action of MP 
To determine whether MP acts specifically via the glucocorticoid (GC)-receptor to induce ADAMTS2, the 
inactive GC-analog RU486 was used (Fig. 3). In PBMC, MP increased ADAMTS2 mRNA expression in a dose-
dependent manner, with 0.1 µM MP increasing expression 270-fold (± 132) and 1 µM MP inducing levels that 
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were 575-fold (± 125) above controls. RU486 alone (2 µM) had no effect on ADAMTS2 mRNA (1.35-fold ± 
0.33). However, the effect of MP on ADAMTS2 expression levels was blocked completely by RU486 at both 
doses of MP (0.1 µM MP 2.2-fold ± 1.2, and 1 µM MP 2.3-fold ± 0.7). These findings indicate that ADAMTS2 
induction by GC is mediated by the glucocorticoid receptor (GCR). 
 
Fig. 3 Effect of RU486 and methylprednisolone (MP) on ADAMTS2 mRNA levels in blood mononuclear cells 
(PBMC). Cells were incubated for 5 days with RU486 (2 µM), MP (as indicated), and a combination of both, or 
remained untreated. Baseline is untreated cells and was set as 1; n=3; mean±SD; *p<0.05 
 
 
Western blot analysis of ADAMTS2 protein 
Next, we analyzed the effect of MP on ADAMTS2 protein using PBMC isolated from bovine blood. The bovine 
system was used because of the availability of a well-established antibody against bovine ADAMTS2 suitable 
for Western blotting. After incubation with MP, elevated concentrations of ADAMTS2 protein were detected. As 
can be seen in Fig. 4, there was a substantial increase of the 150 kDa form of ADAMTS2, a form that displays 
amino-procollagen peptidase activity. Densitometric analysis showed an induction of 148-, 48-, and 2.2-fold for 
animals 1, 2, and 3, respectively. A similar pattern was seen for the other active form of ADAMTS2 (104 kDa 
band) except for animal 3, where we found a faint band in untreated cells and no induction by MP (Fig. 4). 
 
Fig. 4 Western blot analysis of ADAMTS2 in bovine macrophages. Cells were incubated for 5 days with 1 µM 
MP or remained untreated. Four different ADATMS2 products are detected, two of them (150 and 104 kDa) 
displaying aminoprocollagen peptidase activity are shown [13] 
 
 
MP-induced expression of ADAMTS genes 
We have then asked whether the pronounced effect of GC on ADAMTS2 expression would also extend to other 
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closely related or more distantly related ADAMTS mRNAs. Compared to ADAMTS2, with an average 150-fold 
induction (Fig. 5), the closely related ADAMTS3 and 14 mRNAs showed only a 3- and 13-fold induction, 
respectively. Also, the distantly related ADAMTS9, 20, and 1 genes gave only a 4- to 11-fold induction in PBMC 
treated with MP (Fig. 5). Hence, while GC treatment strongly induces ADAMTS2, there was only a weak 
induction of these selected ADAMTS mRNAs. 
 
Fig. 5 Effect of methylprednisolone (MP) on mRNA levels of ADAMTS2, 3, 14, 9, 20, 1 in PBMC (n = 3, except 
ADAMTS1 n = 4). Cells were incubated for 5 days with 1 µM MP or remained untreated. Baseline is untreated 
cells and was set as 1; mean±SD 
 
 
Fig. 6 Effect of methylprednisolone (MP) on ADAMTS2 mRNA levels in cell lines of the monocyte macrophage 
lineage MM6 (n = 3), and THP-1 (n = 4), in epithelial cell lines A549 (n = 3), Calu-3 (n = 3), Colo320 (n = 4), 
and BT-20 (n = 4) and in fibroblast cell lines MRC-5, WI-38, NHDF-c adult cheek, and NHDF-c adult upper 
arm (all n = 3), respectively. Cells were incubated for 5 days with 1 µM MP or remained untreated. Baseline is 
untreated cells and was set as 1; mean ±S.D.; *p < 0.05 
 
 
MP-induced ADAMTS2 mRNA expression in cell lines representing different tissues 
To further investigate the cellular specificity of GC-mediated upregulation of ADAMTS2, we studied cell lines of 
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epithelial origin and fibroblast lines, the latter being a typical source of ADAMTS2. In line with the results 
obtained using blood monocytes, ADAMTS2 mRNA expression was increased after stimulation with 1 µM MP 
for 5 days in cell lines of the monocyte lineage Mono Mac 6, and THP-1, both established from acute monocytic 
leukemias. In Mono Mac 6, induction of mRNA level was 7.2-fold±l, in THP-1 cells, 19.9-fold ± 2.5 (Fig. 6). 
By contrast, epithelial cell lines did not show a statistically significant GC-inducible ADAMTS2 mRNA. In the 
epithelial cell line A549, ADAMTS2 mRNA increased after MP-treatment 2.45-fold ± 0.08, in the Calu-3 cell 
line, a 0.45-fold ± 0.04 decrease could be detected, while Colo320 and BT-20 cell line showed an increase of 
3.96-fold ± 3.20 and 3.93-fold ± 2.76, respectively (Fig. 6). Also, in the fibroblast cell lines MRC-5 (1.44-fold ± 
0.3), WI-38 (1.13-fold ± 0.4), NHDF-c adult cheek (1.75-fold ± 0.7), and NHDF-c adult upper arm (1.24-fold ± 
0.3), a marginal and statistically not significant increase in ADAMTS2 mRNA expression could be detected. 
Discussion 
In earlier experiments, using gene expression arrays, we noted a strong induction of ADAMTS2 mRNA 
expression in MDM derived from patients who received oral treatment with GC 
(http://www.ncbi.nlm.nih.gov/geo/, accession number GSE8608). We verified this effect of GC treatment on 
ADAMTS2 gene expression in vitro using cells of the monocyte/macrophage lineage (Fig. 1, 2). Although the 
impact of GC on global gene expression has been studied [34-37], this is a novel finding not reported in the 
literature before. This effect may have been overlooked because it takes 48 h to reach its full magnitude, with a 
plateau at 120 h (Fig. 1c). 
Dose-response analysis shows effects on ADAMTS2 mRNA expression with GC concentrations that are in the 
physiological range (0.1 µM), with more pronounced effects at levels of 1 µM and beyond, as seen with GC 
therapy [38] (Fig. 1b). Therefore, it is plausible that this effect would be observed in vivo in patients treated with 
GC for several days. 
We observed such a strong MP-mediated ADAMTS2 gene expression among leukocytes of the monocytic 
lineage, but not in cultured T and B cells (Fig. 2). In phytohemag-glutinin (PHA)-activated T lymphocytes, a 
moderate (32.5 ± 49.6) effect of MP treatment was detected. In any event, co-stimulation of macrophages by, for 
instance, LPS is not required for GC to induce ADAMTS2 in these cells, as we grow our cultures under stringent 
exclusion of LPS contamination. When looking at macrophages from tissue, we could also see induction in cells 
from the lung (alveolar macrophages), and this induction was also about 200-fold (Fig. 2). In comparison to 
CD14++ monocyte-derived macrophages, the lower induction of ADAMTS2 mRNA may be due to a different 
maturation process in alveolar macrophages. While the induction of ADAMTS2 by glucocorticoids in alveolar 
macrophages was done on samples obtained during diagnostic procedures from patients with inflammatory lung 
disease, we assume that the same type of response will be seen in macrophages from healthy individuals, but this 
will have to be formally demonstrated. As ADAMTS2 can be induced by GC in primary alveolar macrophages 
and in monocyte-derived macrophages, the latter cells are a useful model for tissue macrophages, and we suggest 
that induction of ADAMTS2 by GCs will also be seen in primary macrophages from other tissues. 
We then asked whether the strong induction of ADAMTS2 in macrophages would also lead to a similar induction 
of protein. For this, we turned to the bovine system, where adequate monoclonal antibodies for detection of 
ADAMTS2 by Western blots are available [13]. We could show a pronounced induction of the ADAMTS2 
protein in monocyte-derived macrophages generated from three of four animals (Fig. 4). We do not know why 
induction did not occur in animal no. 4, but there may be interindividual variation. Using RT-PCR, we found a 
higher basal level of ADAMTS2 mRNA expression in cow compared to human samples (data not shown). Of 
note, we did see induction of bovine ADAMTS2 mRNA in all animals including animal no. 4, suggesting that the 
failure to produce protein might be at the posttranscriptional level. There also may be enhanced degradation of 
the protein by other enzymes in animal no. 4, as we analyzed samples without addition of proteinase inhibitors. 
We also performed an ADAMTS2 activity assay using monocytes/macrophages conditioned culture medium and 
aminoprocollagen type I, a substrate of ADAMTS2 (data not shown). However, due to massive production of 
various proteases by monocytes/macrophages, aminoprocollagen type I was rapidly degraded preventing the 
specific evaluation of ADAMTS2 activity. Moreover, as most of these secreted proteases belong to the 
metalloproteinase family, their inhibition would also alter the ADAMTS2 activity, explaining why we were 
unable to directly measure the aminoprocollagen peptidase activity in the various conditioned media. However, 
we were able to demonstrate the presence of ADAMTS2 polypeptides with apparent sizes of 150 and 104 kDa, 
which previously have been shown to be catalytically active [13], 
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Upon testing for GC induction of other ADAMTS mRNAs, we did not find such a pronounced effect as seen for 
ADAMTS2 (Fig. 5). The additional genes were selected based on the evolutionary relationship as reviewed by 
Apte [11]. We have tested the closely related ADAMTS3 and 14 genes and the more distant genes ADAMTS9, 20, 
and 1, which, in contrast to ADAMTS2, belong to a proteoglycan-processing superclade. All of the selected genes 
showed only a moderate induction between 4- and 13-fold, which is low compared to ADAMTS2 which was 
induced 150-fold in the same experiments. In the original description, ADAMTS1 was shown to be induced by 
interleukin-1 and lipopolysaccharide suggesting a role in inflammatory processes [39]. Therefore, a modulation 
by GC treatment could have been expected, but the effect seen was only a 4-fold induction in GC-treated MDM 
(Fig. 5). Taken together, the strong induction by GC treatment in MDM of ADAMTS2 appears to be selective and 
does not extend to a series of other representative ADAMTS genes. 
ADAMTS2 is known to be produced by various mesenchymal cells such as adipocytes, smooth muscle cells, and 
fibroblasts [25]. Therefore, we speculated that MP treatment would up-regulate this gene in these cells as well. 
Surprisingly there was no or only a modest change in ADAMTS2 mRNA levels in the cell lines of fibroblast and 
epithelial origin (Fig. 6). Of note, we did see ready induction of the gene in two cell lines of monocytic origin. 
This argues in favor of a tissue-specific induction of ADAMTS2 by GC. We do not see a direct link between 
monocytes/macrophages and mesenchymal cells. Expression of ADAMTS2 in our culture was indeed a surprise. 
Two hypothesis can be made: Treatment of macrophages by GC induce their differentiation as "alternatively 
activated macrophages". These alternatively activated macrophages are anti-inflammatory and pro-fibrotic, and 
induce wound repair [40]. In this context, production of an enzyme by alternatively activated macrophages, 
which is critical for collagen maturation, but quite limiting and poorly inducible in fibroblasts, makes sense and 
would favor collagen and extracellular matrix accumulation. As an alternative hypothesis, ADAMTS2 may be 
directly involved in the antiinflammatory process by cleavage of a so far unidentified substrate (e.g., cytokine, 
receptor, inflammation mediator) leading to its activation or inhibition. Further investigations will be required to 
answer these questions. 
When looking at the mechanism involved in induction, we were interested to see whether this would involve the 
glucocorticoid receptor. For this, we treated macrophages with the steroid-receptor blocker RU486 [41]. These 
data did show a potent and complete inhibition of GC action even at equimolar concentrations of the GC and the 
inhibitor (Fig. 3). This finding suggests that MP acts via the GCR to induce ADAMTS2. The GCR may act on 
transcription either indirectly or by binding to other transcription factors in an enhanceosome [42]. An enhan-
ceosome is a complex consisting of transcription activators that promote the interaction and cooperative binding 
to the DNA and allows additive and synergistic effect on gene transcription [43]. When inspecting the 5' region 
of the human ADAMTS2 gene, we noted two potential GCR binding sites (data not shown) suggesting that the 
GCR may act by directly binding to the promoter. 
What could the role of the induction of ADAMTS2 by GC be? ADAMTS2 is required for maturation and 
assembly of collagen fibers and therefore for production of the extracellular matrix [13]. A defect in ADAMTS2 
function leads to the dermatosparactic type of Ehlers-Danlos syndrome [44]. Therefore, induction of the gene by 
GC will favor generation of proper ECM. This may be important in late-phase inflammation, where lesions 
undergo repair. The question is whether this will occur under physiological conditions. In fact, the concentration 
of 0.1 µM reflects a level that is seen for steroids like Cortisol where an average 8 A.M. serum level is 0.3 µM. 
The data suggest that GC treatment of patients may be sufficient to induce ADAMTS2 expression in 
macrophages. Analysis of individual samples from our initial array pool using RT-PCR demonstrated that two 
patients without systemic GC treatment showed a low level of ADAMTS2 transcripts (2.5-fold higher than in 
cells from healthy controls). By contrast, macrophages from three cases treated with oral methylprednisolone had 
high levels of ADAMTS2 mRNA (35.5-fold higher than in cells from healthy controls). These data show that 
therapy with GC can induce ADAMTS2 transcriptional expression in macrophages in vivo. 
There certainly is the possibility that ADAMTS2 has additional properties. Potential targets are those containing 
thrombospondin repeats, and here, one candidate molecule would be properdin. As properdin is an enhancer of 
complement activation [45, 46], a digestion of properdin might lead to reduced complement activity and, 
therefore, inflammation. 
Taken together, we demonstrate herein a strong induction of ADAMTS2 mRNA and protein by glucocorticoids in 
a macrophage-restricted manner. The biological consequences of this induction remain elusive at this point. 
Given the fact that GCs are among the most widely used immunosuppressive drugs, elucidation of the action of 
macrophage-produced ADAMTS2 will be an important topic. 
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